4Plutzky J. Inflammatory pathways in atherosclerosis and acutecoronary syndromes [ J]. Am J Cardiol, 2001, 88: 10K-15K.
5Seino Y, Ikeda M, Ymamato K, et al. Intereukin-6gene tran-scripts are expressed in human atherosclerotic lesion [ J ]. Cytokine,1994, 26: 141.
6ZHANG M, CHEN L. Status of cytokines in ischemia reperfu-sion induced heart injury [ J]. Cardiovase Hematol Disord Drug Targets,2008, 8 (3): 161 -172.
7GargR, Chaudhuri A, MunschauerF, et al. Hyperglycemia,insulin, and acuteischemic stroke: a mechanistic justification for a trial ofinsulin infusion therapy [ J]. Stroke, 2006, 37: 267 -273.
8Gaiis ZS, Khatri JJ. Matrix metalloproteinases in vascular re-modeling and atherogenesis : the good, the bad,and the ugly [ J ] . CircRes, 2002, 90 (3): 251 -262.
9Morishige K, Shimokawa H, Matsumoto Y, et al. Overexpres-sion of matrix metallo - proteinase-9 promotes intravascular thrombus forma-tion in porcine coronary arteries in vivo [ J]. Cardiovase Res, 2003, 57 :572 -585.
10Papalambros E, Sigala F, Georgopulos S, et al. Vascular en-dothelial growth factor and matrix metalloproteinase 9 expression inhuman ca-rotid atherosderotic plaques : relationship with plaquedestabilization via neo-vascularization [J] . Cerebrovasc Dis, 2004, 18 (2) : 160 - 165.
